Diabetes mellitus and cerebrovascular disease

Neuroepidemiology

Volumn 18, Issue 1, 1999, Pages 1-14

  Lukovits, Timothy G ^a   Mazzone, Theodore ^a   Gorelick, Philip B ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Diabetes mellitus; Stroke

Indexed keywords

ATHEROSCLEROSIS; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; EXERCISE; HUMAN; PRIMARY PREVENTION; REVIEW; RISK ASSESSMENT; WEIGHT REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; CEREBROVASCULAR DISORDERS; DIABETES COMPLICATIONS; DIABETES MELLITUS; HUMANS; MIDDLE AGED;

EID: 0032890150     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026190     Document Type: Review

References (119)

1. Helgason CM: Blood glucose and stroke. Stroke 1988;19:1049-1053.
2. McCall AL: The impact of diabetes on the CNS. Diabetes 1992;41:557-570.
3. Biller J, Love BB: Diabetes and stroke. Clin Diabetes 1991;9:67-79.
4. Chukwuma C, Tuomilehto J: Diabetes and the risk of stroke. J Diabetes Complications 1993;7:250-262.
5. Bell DS: Stroke in the diabetic patient. Diabetes Care 1994;17:213-219.
6. Caplan LR: Diabetes and brain ischemia. Diabetes 1996;45(suppl 3): S95-S97.
7. Currie CJ, Morgan CL, Gill L, Stott NCH, Peters JR: Epidemiology and costs of acute hospital care for cerebrovascular disease in diabetic and nondiabetic populations. Stroke 1997;28:1142-1146.
8. Report of the Expert Committee on the Diagnosis and Classification of Diabetes mellitus. Diabetes Care 1997;20:1183-1197.
9. Grunnet ML: Cerebrovascular disease: Diabetes and cerebral atherosclerosis. Neurology 1963;13:486-491.
10. Kane WC, Aronson SM: Frequency and topographic distribution of intracranial vascular diseases in diabetic patients: A necropsy survey. Am J Pathol 1968;52:71a-72a.
11. Aronson SM: Intracranial vascular lesions in patients with diabetes mellitus. J Neuropathol Exp Neurol 1973;32:183-196.
12. Peress NS, Kane WC, Aronson SM: Central nervous system findings in a tenth decade autopsy population. Prog Brain Res 1973;40:473-483.
13. Bell ET: A postmortem study of vascular disease in diabetics. Arch Pathol 1952;53:444-455.
14. Alex M, Baron EK, Goldenberg S, Blumenthal HT: An autopsy study of cerebrovascular accident in diabetes mellitus. Circulation 1962;25: 663-673.
15. Caplan LR: Intracranial branch atheromatous disease: A neglected, understudied, and underused concept. Neurology 1989;39:1246-1250.
16. Reske-Nielsen E, Lundbaek K, Rafaelsen OJ: Pathological changes in the central and peripheral nervous system of young long-term diabetics. Diabetologia 1965;1:233-241.
17. Kameyama M, Fushimi H, Udaka F: Diabetes mellitus and cerebral vascular disease. Diabetes Res Clin Pract 1994;24(suppl):S205-S208.
18. Flora GC, Baker AB, Loewenson RB, Klassen AC: A comparative study of cerebral atherosclerosis in males and females. Circulation 1968;38:859-869.
19. Andresen JL, Rasmussen LM, Ledet T: Diabetic macroangiopathy and atherosclerosis. Diabetes 1996; 45(suppl 3):S91-S94.
20. Fischer VW, Barner HB, Leskiw ML: Capillary basal laminar thickness in diabetic human myocardium. Diabetes 1979;28:713-719.
21. Factor SM, Okun EM, Minase T: Capillary microaneurysms in the human diabetic heart. N Engl J Med 1980;302:384-388.
22. D'Agostino RB, Wolf PA, Belanger AJ, Kannel WB: Stroke risk profile: Adjustment for antihypertensive medication. Stroke 1994;25:40-43.
23. Davis PH, Dambrosia JM, Schoenberg BS, Schoenberg DG, Pritchard DA, Lilienfeld AM, Whisnant JP: Risk factors for ischemic stroke: A prospective study in Rochester, Minnesota. Ann Neurol 1987;22: 319-327.
24. Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434-444.
25. Tuomilehto J, Rastenyte D, Jousilahti P, Sarti C, Vartiainen EV: Diabetes mellitus as a risk factor for death from stroke. Stroke 1996;27: 210-215.
26. Abbott RD, Donahue RP, MacMahon SW, Reed DM, Yano K: Diabetes and the risk of stroke: The Honolulu Heart Program. JAMA 1987;257:949-952.
27. Barrett-Connor E, Khaw K-T: Diabetes mellitus: An independent risk factor for stroke? Am J Epidemiol 1988;128:116-123.
28. Kuusisto J, Mykkanen L, Pyorala K, Laakso M: Non-insulin-dependent diabetes and its metabolic control are important predictors of stroke in elderly subjects. Stroke 1994;25: 1157-1164.
29. Lindegard B, Hillbom M: Associations between brain infarction, diabetes and alcoholism: Observations from the Gothenburg population cohort study. Acta Neurol Scand 1987; 75:195-200.
30. Ellekjaer EF, Wyller TB, Sverre JM, Holmen J: Lifestyle factors and risk of cerebral infarction. Stroke 1992; 23:829-834.
31. Jamrozik K, Broadhurst RJ, Anderson CS, Stewart-Wynne EG: The role of lifestyle factors in the etiology of stroke. Stroke 1994;25:51-59.
32. Haapaniemi H, Hillbom M, Juvela S: Lifestyle-associated risk factors for acute brain infarction among persons of working age. Stroke 1997; 28:26-30.
33. Whisnant JP, Wiebers DO, O'Fallon WM, Sicks JD, Frye RL: A population-based model of risk factors for ischemic stroke: Rochester, Minnesota. Neurology 1996;47:1420-1428.
34. Whisnant JP: Modeling of risk factors for ischemic stroke: The Willis Lecture. Stroke 1997;28:1839-1844.
35. Deckert T, Poulsen JE, Larsen M: Prognosis of diabetics with diabetes onset before the age of thirty-one. Diabetologia 1978;14:363-370.
36. Turnbridge WMG: Factors contributing to deaths of diabetics under fifty years of age. Lancet 1981;ii: 569-572.
37. Bogousslavsky J, Regli F, Van Melle G: Risk factors and concomitants of internal carotid artery occlusion or stenosis. Arch Neurol 1985;42:864-867.
38. Yasaka M, Yamaguchi T, Shichiri M: Distribution of atherosclerosis and risk factors in atherothrombotic occlusion. Stroke 1993;24:206-211.
39. Mast H, Thompson JLP, Lee S-H, Mohr JP, Sacco RL: Hypertension and diabetes mellitus as determinants of multiple lacunar infarcts. Stroke 1995;26:30-33.
40. You R, McNeil JJ, O'Malley HM, Davis SM, Donnan GA: Risk factors for lacunar infarction syndromes. Neurology 1995;45:1483-1487.
41. Bernick C, Longstreth WT, Manolio TA, Jungreis CA, Price TR, Bryan N: Clinical factors associated with lacunes on cranial magnetic resonance imaging or 3, 660 elderly people: The Cardiovascular Health Study. Abstr 22nd Int Joint Conf Stroke Cereb Circ, 1997.
42. Longstreth WT, Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis CA, Enright PL, O'Leary D, Fried L: Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3,301 elderly people: The Cardiovascular Health Study. Stroke 1996;27:1274-1282.
43. Ylikoski A, Erkinjuntti T, Raininko R, Sarna S, Sulkava R, Tilvis R: White matter hyperintensities on MRI in the neurologically nondiseased elderly. Stroke 1995;26:1171-1177.
44. Perlmuter LC, Hakami MK, Hodgson-Harrington C, Ginsberg J, Katz J, Singer DE, Nathan DM: Decreased cognitive function in aging non-insulin-dependent patients. Am J Med 1984;77:1043-1048.
45. Ryan CM: Neurobehavioral complications of type 1 diabetes: Examination of possible risk factors. Diabetes Care 1988;11:86-93.
46. Leibson CL, Rocca WA, Hanson VA, Cha R, Kokmen E, O'Nrien PC, Palumbo PJ: Risk of dementia among persons with diabetes mellitus: A population-based cohort study. Am J Epidemiol 1997;145: 301-308.
47. Heitner J, Dickson D: Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects. Neurology 1997;49:1306-1311.
48. American Diabetes Association: Diabetes 1996: Vital statistics, pp 21-25.
49. Sacco RL, Hauser WA, Mohr JP: Hospitalized stroke in Blacks and Hispanics in Northern Manhattan. Stroke 1991;22:1491-1496.
50. Rohr J, Kittner S, Feeser B, Hebel JR, Whyte M-G, Weinstein A, Kanarak N, Buchholz D, Earley C, Johnson C, Macko R, Price T, Sloan M, Stern B, Wityk R, Wozniak M, Sherwin R: Traditional risk factors and ischemic stroke in young adults: The Baltimore-Washington Cooperative Young Stroke Study. Arch Neurol 1996;53:603-607.
51. Sacco RL, Gu Q, Boden-Albala BM, Kargman DE, Weslow RG, Homma S, Tullio MR: Race-ethnic differences in the magnitude of stroke risk factors: The Northern Manhattan Stroke Study. Abstr 21st Int Joint Conf Stroke Cereb Circ, 1996.
52. Tuhrim S, Roman S, Weinberger J, Horowitz D, Goldman M, Godbold J: Does risk of stroke associated with diabetes differ by ethnicity? Abstr 21st Int Joint Conf Stroke Cereb Circ, 1996.
53. Kawamori R, Yamasaki Y, Matsushima H, Nao K, Hougaka H, Maeda H, Handa N, Matsumoto M, Kamada T: Prevalence of carotid atherosclerosis in diabetic patients. Diabetes Care 1992;15:1290-1294.
54. Pujia A, Gnasso A, Irace C, Colonna A, Mattioli PL: Common carotid arterial wall thickness in NIDDM subjects. Diabetes Care 1994;17:1330-1336.
55. O'Leary DH, Polak JF, Kronmal RA, Savage PJ, Borhani NO, Kittner SJ, Tracy R, Gardin JM, Price TR, Furburg CD: Thickening of the carotid wall: A marker for atherosclerosis in the elderly? Stroke 1996; 27:224-231.
56. Niskanen L, Rauramaa R, Miettinen H, Haffner SM, Mercuri M, Uusitupa M: Carotid artery intimamedia thickness in elderly patients with NIDDM and in nondiabetic subjects. Stroke 1996;27:1986-1992.
57. Wagenknecht LE, D'Agostino R, Savage PJ, O'Leary DH, Saad MF, Haffner SM: Duration of diabetes and carotid wall thickness: The Insulin Resistance Atherosclerosis Study. Stroke 1997;28:999-1005.
58. Howard G, Manolio TA, Burke GL, Wolfson SK, O'Leary DH: Does the association of risk factors and atherosclerosis change with age? Stroke 1997;28:1693-1701.
59. Lehto S, Ronnemaa T, Pyorala K, Laakso M: Predictors of stroke in middle-aged patients with non-insulin dependent diabetes. Stroke 1996; 27:63-68.
60. Haheim LL, Holme I, Hjermann I, Leren P: Nonfasting serum glucose and the risk of fatal stroke in diabetic and nondiabetic subjects. Stroke 1995;26:774-777.
61. Burchfiel CM, Curb JD, Rodriguez BL, Abbott RD, Chiu D, Yano K: Glucose and 22-year stroke incidence: The Honolulu Heart Program. Stroke 1994;25:951-957.
62. Reed DM, Resch JA, Hayashi T, MacLean C, Yano K: A prospective study of cerebral artery atherosclerosis. Stroke 1988;19:820-825.
63. Toyry JP, Niskanen LK, Lansimies EA, Partanen KPL, Uusitupa MIJ: Autonomic neuropathy predicts the development of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke 1996;27: 1316-1318.
64. Miettinen H, Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects. Stroke 1996;27:2033-2039.
65. Petitti DB, Bhatt H: Retinopathy as a risk factor for nonembolic stroke in diabetic subjects. Stroke 1995;26: 593-596.
66. Jorgensen HS, Nakayama H, Raaschou HO, Olsen TS: Stroke in patients with diabetes: The Copenhagen Stroke Study. Stroke 1994;25: 1977-1984.
67. Adams HP Jr, Putnam SF, Kassell NF, Torner JC: Prevalence of diabetes mellitus among patients with subarachnoid hemorrhage. Arch Neurol 1984;41:1033-1035.
68. de Courten-Meyers GM, Kleinholz M, Holm P, Schmitt GZ, Wagner KR, Myers RE: Hemorrhagic infarct conversion in experimental stroke. Ann Emerg Med 1992;21:120-125.
69. Broderick JP, Hagen T, Brott T, Tomsick T: Hyperglycemia and hemorrhagic transformation of cerebral infarcts. Stroke 1996;26:484-487.
70. Hier DB, Foulkes MA, Swiontoniowski M, Sacco RL, Gorelick PB, Mohr JP, Price TR, Wolf PA: Stroke recurrence within 2 years after ischemic infarction. Stroke 1991;22: 155-161.
71. Petty GW, Brown RD, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO: Survival and recurrence after first cerebral infarction: A population-based study in Rochester, Minnesota, 1975-1989. Neurology 1998;50:208-216.
72. Sacco RL, Shi T, Zamanillo MC, Kargman DE: Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community: The Northern Manhattan Stroke Study. Neurology 1994;44: 626-634.
73. Alter M, Lai SM, Friday G, Singh V, Kumar VM, Sobel E: Stroke recurrence in diabetics: Does control of blood glucose reduce risk? Stroke 1997;28:1153-1157.
74. Pulsinelli WA, Waldman S, Rawlinson D, Plum F: Moderate hyperglycemia augments ischemic brain damage: A neuropathologic study in the rat. Neurology 1982;32:1239-1246.
75. Yip PK, He YY, Hsu CY, Garg N, Marangos P, Hogan EL: Effect of plasma glucose on infarct size in focal cerebral ischemia-reperfusion. Neurology 1991;41:899-905.
76. Pulsinelli WA, Levy DE, Sigsbee B, Scherer P, Plum F: Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus. Am J Med 1983;74:540-544.
77. The NINDS t-PA Stroke Study Group: Generalized efficacy of t-PA for acute stroke: Subgroup analysis of the NINDS t-PA Stroke Trial. Stroke 1997;28:2119-2125.
78. Bentsen N, Larsen BO, Lassen NA: Chronically impaired autoregulation of cerebral blood flow in long-term diabetics. Stroke 1975;6:497-502.
79. Dandona P, James IM, Newbury PA, Woollard ML, Beckett AG: Cerebral blood flow in diabetes mellitus: Evidence of abnormal cerebrovascular reactivity. BMJ 1978;ii: 325-326.
80. Aronson D, Rayfield EJ, Chesebro JH: Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction. Ann Intern Med 1997;126:296-306.
81. Woo E, Ma JTC, Robinson JD, Yu YL: Hyperglycemia is a stress response in acute stroke. Stroke 1988; 19:1359-1364.
82. Matchar DB, Divine GW, Heyman A, Feussner JR: The influence of hyperglycemia on outcome of cerebral infarction. Ann Intern Med 1992; 117:449-456.
83. Gray CS, French JM, Bates D, Cartlidge NEF, Venables GS, James OFW: Increasing age, diabetes mellitus and recovery from stroke. Postgrad Med J 1989;65:720-724.
84. Davalos A, Fernandez-Real JM, Ricart W, Soler S, Molins A, Planas E, Genis D: Iron-related damage in acute ischemic stroke. Stroke 1994; 25:1543-1546.
85. Wingard DL, Barrett-Connor E, Criqui MH, Suarez L: Clustering of heart disease risk factors in diabetic compared to nondiabetic adults. Am J Epidemiol 1983;117:19-26.
86. Haffner SM: Management of dyslipidemia in adults with diabetes. Diabetes Care 1998;21:160-178.
87. VanGaal L, Rillaerts E, Croten W, DeLeeuw I: Relationship of body fat distribution pattern to atherogenic risk factors in NIDDM: Preliminary results. Diabetes Care 1988;11:103-106.
88. Lyons TJ: Glycation and oxidation: A role in the pathogenesis of atherosclerosis. Am J Cardiol 1993;71: 26B-31B.
89. Vlassara H: Recent progress on the biologic and clinical significane of advanced glycosylation end products. J Lab Clin Med 1994;124:19-30.
90. Colwell JA, Winocour PD, Halushka PV: Do platelets have anything to do with diabetic microvascular disease? Diabetes 1983; 32(suppl 2):14-19.
91. Davi G, Catalano I, Averna M, Notarbartolo A, Strano A, Ciabattoni G, Patrono C: Thromboxane biosynthesis and platelets in type II diabetes mellitus. N Engl J Med 1990;322:1769-1774.
92. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA: Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 1993;88: 2510-2516.
93. Cohen RA: Dysfunction of vascular endothelium in diabetes mellitus. Circulation 1993;87(suppl V): V67-V76.
94. McGill JB, Schneider DJ, Arfken CL, Lucore CL, Sobel BE: Factors responsible for impaired fibrinolysis in obese patients and NIDDM patients. Diabetes 1994;43:104-109.
95. Stout RW: Insulin and atheroma: 20-year perspective. Diabetes Care 1990;13:631-654.
96. DeFronzo RA: The effect of insulin on renal sodium metabolism: A review with clinical implications. Diabetologia 1981;21:165-171.
97. Rowe JW, Young JB, Minaker KL, Stevens AL, Pallotta J, Landsberg L: Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 1981;30:219-225.
98. Singer DE, Nathan DM, Anderson KM, Wilson PW, Evans JC: Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study. Diabetes 1992;41: 202-208.
99. Klein R: Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 1995;18:258-268.
100. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986.
101. Turner R, Cull C, Holman R: United Kingdom Prospective Diabetes Study 17: A 9-year update of a randomized, controlled trial of the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Ann Intern Med 1996;124: 136-145.
102. UK Prospective Diabetes Study Group: UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance. Diabetologia 1991;34:877-890.
103. Malmberg K, for the DIGAMI (Diabetes mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group: Prospective randomized study of intensive insulin treatment on long-term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ 1997;314: 1512-1515.
104. Malouf R, Brust JCM: Hypoglycemia: Causes, neurological manifestations, and outcome. Ann Neurol 1985;14:421-430.
105. American Diabetes Association: Standards of medical care for patients with diabetes mellitus. Diabetes Care 1998;21(suppl 1):S23-S31.
106. Pyorala K, Pedersen T, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G: Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. Diabetes Care 1997;20:614-620.
107. Sivenius J, Laakso M, Riekkinen P, Smets P, Lowenthal A: European Stroke Prevention Study: Effectiveness of antiplatelet therapy in diabetic patients in secondary prevention of stroke. Stroke 1992; 23:851-854.
108. ISIS-2 Collaborative Group: Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction. Lancet 1988;2:349-360.
109. Colwell JA, Bingham SF, the Cooperative Study Group: VA Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene. Haemostasis 1986;16:433-438.
110. Antiplatelet Trialists' Collaboration: Collaborative overview of randomized trials of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308:81-106.
111. Keegan A, Walbank H, Cotter MA, Cameron NE: Chronic vitamin E treatment prevents defective endothelium-dependent relaxation in diabetic rat aorta. Diabetologia 1995;38:1475-1478.
112. Ting HH, Timimi FK, Boles KS, Creager SJ, Ganz P, Creager MA: Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1996; 97:22-28.
113. Brownlee M, Vlassara H, Kooney T, Ulrich P, Cerami A: Amino-guanidine prevents diabetes-induced arterial wall protein cross-linking. Science 1986;232:1629-1632.
114. Soulis-Liparota T, Cooper M, Papazoglou D, Clarke B, Jerums G: Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat. Diabetes 1991; 40:1328-1334.
115. Beisswanger P, Howell S, Touchette A, Lal S, Szwergold B, Rohlf J: Metfromin reduces systemic methylglyoxal levels in NIDDM (abstract). Diabetes 1997;46(suppl 1):74A.
116. Gutowski C, Prawius H, Flocke S, Zyzanski S, Foti F, Dreyfus, Clark E, Babirak S: Prevalence of hyperhomocysteinemia in a clinical practice of diabetic patients and their responses to treatment (abstract). Diabetes 1997;46(suppl 1): 48A.
117. Hoffmann MA, Kohl B, Zumbach MS, Borcea V, Bierhaus A, Henkels M, Amiral J, Fiehn W, Ziegler R, Wahl P, Nawroth PP: Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM. Diabetes Care 1997;20:1880-1886.
118. Hoogeveen E, Heine R, Kostense P, Jakobs C, Bouter L, Stehouwer C: Increased risk of cardiovascular disease by high homocysteine is related to glucose tolerance: The Hoorn Study (abstract). Diabetes 1997;46(suppl 1):25A.
119. Eriksson K-F, Lindgarde F: Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. Diabetologia 1991;34:891-898.